Nothing Special   »   [go: up one dir, main page]

DE60331546D1 - Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung - Google Patents

Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung

Info

Publication number
DE60331546D1
DE60331546D1 DE60331546T DE60331546T DE60331546D1 DE 60331546 D1 DE60331546 D1 DE 60331546D1 DE 60331546 T DE60331546 T DE 60331546T DE 60331546 T DE60331546 T DE 60331546T DE 60331546 D1 DE60331546 D1 DE 60331546D1
Authority
DE
Germany
Prior art keywords
seq
cosmetics
fields
treatment
aspartic proteases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331546T
Other languages
English (en)
Inventor
Dominique Bernard
Bruno Mehul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE60331546D1 publication Critical patent/DE60331546D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60331546T 2002-07-09 2003-07-09 Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung Expired - Lifetime DE60331546D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0208613A FR2842209B1 (fr) 2002-07-09 2002-07-09 Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
PCT/FR2003/002151 WO2004007548A1 (fr) 2002-07-09 2003-07-09 Utilisation de proteases aspartiques dans le domaine cosmetique et therapeutique

Publications (1)

Publication Number Publication Date
DE60331546D1 true DE60331546D1 (de) 2010-04-15

Family

ID=29763673

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331546T Expired - Lifetime DE60331546D1 (de) 2002-07-09 2003-07-09 Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung

Country Status (10)

Country Link
US (2) US7521422B2 (de)
EP (1) EP1519952B1 (de)
JP (1) JP4459808B2 (de)
AT (1) ATE459644T1 (de)
AU (1) AU2003264708A1 (de)
CA (1) CA2491080A1 (de)
DE (1) DE60331546D1 (de)
ES (1) ES2340481T3 (de)
FR (1) FR2842209B1 (de)
WO (1) WO2004007548A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842209B1 (fr) * 2002-07-09 2007-11-23 Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
KR101165848B1 (ko) * 2005-08-18 2012-07-13 (주)아모레퍼시픽 효소 및 아미노산을 함유하는 피부 화장료 조성물
WO2007043404A1 (ja) * 2005-10-11 2007-04-19 Eisai R & D Management Co., Ltd. サスペースノックアウト動物
EP2249853A4 (de) 2008-01-30 2012-12-26 Univ Indiana Res & Tech Corp Peptid-prodrugs auf esterbasis
US8697632B2 (en) 2008-12-19 2014-04-15 Indiana University Research And Technology Corporation Amide based insulin prodrugs
CA2747195A1 (en) * 2008-12-19 2010-07-15 Indiana University Research And Technology Corporation Dipeptide linked medicinal agents
JP5789515B2 (ja) 2008-12-19 2015-10-07 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ インスリン類似体
CA2747499A1 (en) 2008-12-19 2010-06-24 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
US20110076333A1 (en) * 2009-09-25 2011-03-31 Susan Daly Method and compositions for selectively treating skin
CA2802485C (en) 2010-06-16 2019-09-17 Indiana University Research And Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
JP5912112B2 (ja) 2010-06-24 2016-04-27 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ アミド系インスリンプロドラッグ
US8778872B2 (en) 2010-06-24 2014-07-15 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
FR2968201B1 (fr) * 2010-12-07 2017-07-21 Oreal Complexe saspase-flg2, agents modulateurs et utilisations
FR2968303B1 (fr) 2010-12-07 2013-01-18 Oreal Peptides modulateurs du complexe saspase-flg2
FR2968200B1 (fr) * 2010-12-07 2013-01-18 Oreal Agents modulateurs du complexe saspase-flg2 et utilisations
FR2968199B1 (fr) * 2010-12-07 2013-01-18 Oreal Agents modulateurs du complexe saspase-flg2 et peaux grasses
JP6392123B2 (ja) * 2011-12-20 2018-09-19 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ 糖尿病治療のためのｃｔｐ系インスリンアナローグ
FR2991680B1 (fr) * 2012-06-06 2014-09-05 Oreal Composes pour application anti-age et peau seche
JP6387008B2 (ja) 2012-09-26 2018-09-05 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ インスリンアナローグダイマー
WO2014158900A1 (en) 2013-03-14 2014-10-02 Indiana University Research And Technology Corporation Insulin-incretin conjugates
GB201305023D0 (en) * 2013-03-19 2013-05-01 Biocant Associa O De Transfer Ncia De Tecnologia Aspartic proteases
ES2947409T3 (es) 2014-09-24 2023-08-08 Univ Indiana Res & Tech Corp Profármacos de insulina a base de amida lipídica
ES2822994T3 (es) 2014-09-24 2021-05-05 Univ Indiana Res & Tech Corp Conjugados de incretina-insulina
WO2019014744A1 (en) * 2017-07-17 2019-01-24 Universite Laval ASPRV1 AS A NEUTROPHIL SPECIFIC MARKER AND THERAPEUTIC TARGET FOR INFLAMMATORY DISEASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9319104D0 (en) * 1993-09-15 1993-11-03 Unilever Plc Skin care method & composition
FR2761363B1 (fr) 1997-03-28 1999-11-26 Oreal Polypeptide purifie de l'epiderme et son utilisation
FR2767833B1 (fr) * 1997-08-29 2001-03-02 Oreal Polypeptide isole de l'epiderme et son utilisation
DE19950020A1 (de) 1999-10-16 2001-04-19 Henkel Kgaa Verwendung von Zusammensetzungen zur pflegenden Behandlung der Haut
GB0004312D0 (en) 2000-02-23 2000-04-12 Oxagen Limited Test and model for inflammatory disease
US20030206896A1 (en) * 2000-09-13 2003-11-06 O'prey Conor James Cosmetic method
MXPA03002168A (es) 2000-09-13 2003-07-24 Procter & Gamble Metodo cosmetico.
JP2003088388A (ja) * 2001-09-14 2003-03-25 Herikkusu Kenkyusho:Kk 新規な全長ｃＤＮＡ
FR2842209B1 (fr) * 2002-07-09 2007-11-23 Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique

Also Published As

Publication number Publication date
ATE459644T1 (de) 2010-03-15
US7888315B2 (en) 2011-02-15
EP1519952A1 (de) 2005-04-06
US20060240053A1 (en) 2006-10-26
FR2842209B1 (fr) 2007-11-23
AU2003264708A1 (en) 2004-02-02
EP1519952B1 (de) 2010-03-03
US7521422B2 (en) 2009-04-21
WO2004007548A1 (fr) 2004-01-22
ES2340481T3 (es) 2010-06-04
FR2842209A1 (fr) 2004-01-16
JP4459808B2 (ja) 2010-04-28
US20090186821A1 (en) 2009-07-23
CA2491080A1 (fr) 2004-01-22
JP2006511204A (ja) 2006-04-06

Similar Documents

Publication Publication Date Title
DE60331546D1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
ATE333888T1 (de) Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
ATE386538T1 (de) Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden
DE69412243D1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
EA200200755A1 (ru) Опосредованная рецептором nogo блокада роста аксонов
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69427650D1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
DE69942035D1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
DE69938786D1 (de) Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe
DE60045681D1 (de) Vaskuläre adhesionsmoleküle und modulierung ihrer funktion
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
ATE364079T1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
ATE313557T1 (de) Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung
ATE438658T1 (de) Neue polypeptide aus bienengift und dessen gebrauchsverfahren
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DK0842193T3 (da) Somatostatin-analoge cykliske peptider med hæmmende aktivitet på væksthormon
DE60135489D1 (de) Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
FI20012082A0 (fi) Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
ATE417061T1 (de) Scorpionpeptid als blutdrucksenkendes mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition